Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05643794 |
|---|---|
| Brief Title: | A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome |
| First Submitted : | November 30, 2022 |
| First Submitted that Met QC Criteria : | November 30, 2022 |
| First Posted : | December 9, 2022 |
| Last Update Submitted that Met QC Criteria : | December 15, 2023 |
| Last Update Posted : | December 18, 2023 |